Gene · 389421
NIH grants1,664
NIH grants whose papers are about the gene, through NIH's grant-paper links.
541 to 560 of 1,664
Download this page as JSON| Grant | Title | LIN28B papers | Newest fiscal year |
|---|---|---|---|
| K99DK127065 | MC3R inhibition as a strategy to maintain weight loss in obesity | 1 | 2021 |
| P01DK032094 | Red Cell Membrane Studies | 1 | 2021 |
| P01GM099117 | Dissecting the establishment and regulation of human pluripotency | 1 | 2021 |
| P01HL032262 | DEVELOPMENTAL BIOLOGY OF HUMAN ERYTHROPOIESIS | 1 | 2021 |
| P30GM122731 | Molecular Regulation of Cell Development and Differentiation Phase III COBRE | 1 | 2021 |
| P41GM103533 | Comprehensive Biology: Exploiting the Yeast Genome | 1 | 2021 |
| P50CA206963 | SPORE in Myeloid Malignancies | 1 | 2021 |
| R00HD091381 | MKRN3 imprinting, regulation, and action in the control of puberty | 1 | 2021 |
| R00HL138268 | Molecular link between MCU and Mrs2p channels for mitochondrial ion homeostasis and energy metabolism | 1 | 2021 |
| R01AG033605 | Ligand-independent signaling of estrogen receptor beta and the aging brain | 1 | 2021 |
| R01AG056298 | Programming age in iPS models of Alzheimer's disease | 1 | 2021 |
| R01CA057341 | c-Myc Targets in the Pathogenesis of Human Cancers | 1 | 2021 |
| R01CA095441 | The Role of Ribosomal Proteins in the P53-MDM2 Pathway | 1 | 2021 |
| R01CA139067 | miR-200 miRNAs repress tumor metastasis in lung adenocarcinoma | 1 | 2021 |
| R01CA139158 | MiRNAs in hepatocellular carcinoma development and treatment | 1 | 2021 |
| R01CA160331 | Chromatin basis of cellular senescence and its implication in epithelial ovarian cancer | 1 | 2021 |
| R01CA168654 | Cell type and molecular determinants of colorectal cancer initiation downstream of APC inactivation | 1 | 2021 |
| R01CA188134 | Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response | 1 | 2021 |
| R01CA208852 | Necroptotic genes in cancer cellular response to radiation | 1 | 2021 |
| R01CA211614 | Targeting TET1 signaling to treat acute myeloid leukemia | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/grants?page=28